Document is current
Any future updates will be listed below
-
Authors
Ray, Alo
Opyrchal, Mateusz
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30 CA082709)
Vera Bradley Foundation for Breast Cancer
- License Information
-
More Information
Article History
Accepted: 24 April 2025
First Online: 12 June 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Consulting or Advisory Role Company: AstraZeneca Research Funding Company: Pfizer Recipient: You Company: Bayer Recipient: You Company: Alphageneron Recipient: You Company: Werewolf Therapeutics Recipient: You Company: LaNova Recipient: You Company: Krystal Biotech Recipient: You Company: ImmuneOnco Biopharmaceuticals Recipient: You Company: IDEAYA Biosciences Recipient: You Company: PMV Pharma Recipient: You Company: Monte Rosa Therapeutics Recipient: You Company: Immune-Onc Therapeutics Recipient: You.
